HomeGRFS • NASDAQ
Grifols SA - ADR ADR Class B
$7.10
Apr 16, 1:12:11 PM GMT-4 · USD · NASDAQ · Disclaimer
US listed security
Previous close
$6.99
Day range
$6.94 - $7.12
Year range
$5.79 - $9.96
Market cap
5.97B USD
Avg Volume
1.15M
Financials
Income Statement
Revenue
Net income
(EUR)Dec 2024Y/Y change
Revenue
1.98B11.66%
Operating expense
353.12M20.32%
Net income
68.97M76.86%
Net profit margin
3.4958.64%
Earnings per share
EBITDA
495.68M-11.49%
Effective tax rate
60.20%
Total assets
Total liabilities
(EUR)Dec 2024Y/Y change
Cash and short-term investments
1.00B55.40%
Total assets
21.41B1.97%
Total liabilities
12.80B-5.05%
Total equity
8.61B
Shares outstanding
680.41M
Price to book
0.81
Return on assets
5.08%
Return on capital
5.79%
Net change in cash
(EUR)Dec 2024Y/Y change
Net income
68.97M76.86%
Cash from operations
514.62M208.54%
Cash from investing
-178.31M-28.31%
Cash from financing
-27.16M-185.08%
Net change in cash
334.84M658.87%
Free cash flow
162.44M123.56%
About
Grifols, S.A. is a global healthcare company and leading producer of plasma-derived medicines founded in Barcelona, Spain, in 1909. With a workforce of over 23,800 employees, Grifols serves more than 110 countries and regions and maintains a direct presence in over than 30. Principally a producer of blood plasma–based products, a field in which it is the European leader and third largest worldwide, and other biopharmaceuticals, the company is also in transfusion medicine, supplying devices, instruments and reagents for clinical testing laboratories, in addition to clinical diagnostic technologies. Grifols also provides biological supplies for life-science research, clinical trials and for manufacturing pharmaceutical and diagnostic products. Grifols is focused on four main therapeutic areas: immunology, infectious diseases, pulmonology and critical care. Wikipedia
Founded
Nov 18, 1940
Employees
23,833
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu